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Background: Inhalative nanocarriers for local or systemic therapy are promising. Gold nanoparticles (AuNP) have
been widely considered as candidate material. Knowledge about their interaction with the lungs is required,
foremost their uptake by surface macrophages and epithelial cells.
Diseased lungs are of specific interest, since these are the main recipients of inhalation therapy. We, therefore, used
Scnn1b-transgenic (Tg) mice as a model of chronic obstructive pulmonary disease (COPD) and compared uptake
and localization of inhaled AuNP in surface macrophages and lung tissue to wild-type (Wt) mice.
Methods: Scnn1b-Tg and Wt mice inhaled a 21-nm AuNP aerosol for 2 h. Immediately (0 h) or 24 h thereafter,
bronchoalveolar lavage (BAL) macrophages and whole lungs were prepared for stereological analysis of AuNP by
electron microscopy.
Results: AuNP were mainly found as singlets or small agglomerates of ≤ 100 nm diameter, at the epithelial surface
and within lung-surface structures. Macrophages contained also large AuNP agglomerates (> 100 nm). At 0 h after
aerosol inhalation, 69.2±4.9% AuNP were luminal, i.e. attached to the epithelial surface and 24.0±5.9% in
macrophages in Scnn1b-Tg mice. In Wt mice, 35.3±32.2% AuNP were on the epithelium and 58.3±41.4% in
macrophages. The percentage of luminal AuNP decreased from 0 h to 24 h in both groups. At 24 h, 15.5±4.8%
AuNP were luminal, 21.4±14.2% within epithelial cells and 63.0±18.9% in macrophages in Scnn1b-Tg mice. In Wt
mice, 9.5±5.0% AuNP were luminal, 2.2±1.6% within epithelial cells and 82.8±0.2% in macrophages.
BAL-macrophage analysis revealed enhanced AuNP uptake in Wt animals at 0 h and in Scnn1b-Tg mice at 24 h,
confirming less efficient macrophage uptake and delayed clearance of AuNP in Scnn1b-Tg mice.
Conclusions: Inhaled AuNP rapidly bound to the alveolar epithelium in both Wt and Scnn1b-Tg mice. Scnn1b-Tg
mice showed less efficient AuNP uptake by surface macrophages and concomitant higher particle internalization by
alveolar type I epithelial cells compared to Wt mice. This likely promotes AuNP depth translocation in Scnn1b-Tg
mice, including enhanced epithelial targeting. These results suggest AuNP nanocarrier delivery as successful
strategy for therapeutic targeting of alveolar epithelial cells and macrophages in COPD.
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During the last decade, research on interactions between
nanoparticles (NP) and lung tissue has been intensified,
especially in terms of potential health risk of particle
inhalation. The fast development of nanotechnology has
also brought about novel delivery strategies for inhalative
and target-specific drugs for therapeutic application, vac-
cines and diagnostics [1]. There are various definitions of
nano-sized materials. On 18 October 2011 the European
Commission adopted the recommendation on the defin-
ition that “nanomaterial means a natural, incidental or
manufactured material containing particles, in an un-
bound state or as an aggregate or as an agglomerate and
where, for 50% or more of the particles in the number size
distribution, one or more external dimensions is in the
size range 1 nm – 100 nm” [2]. Respiratory tract anatomy,
breathing pattern and particle size are the main factors
determining particle deposition and retention in the differ-
ent pulmonary compartments [3]. Since NP deposit with
high efficiency in the entire respiratory tract, an increasing
number of studies suggest a potential role of inhaled NP
to activate and modulate pathophysiological pathways in
lungs, which are known to be involved in a range of
respiratory diseases, such as chronic obstructive pulmon-
ary disease (COPD), asthma and carcinoma [4]. Gold
nanoparticles (AuNP) have also many applications in
nanomedicine, as they are apparently non-toxic, suitable
for biomedical imaging and can be coated with medical
and pharmacological substrates [5].
In lung defense, one of the key players is the surface
macrophage. Directly exposed to the environment, it is
one of the first cells that comes into contact with in-
haled and deposited particles. Thus, its primary function
is the phagocytic uptake of deposited particles to keep
the lung surface clean, but this also minimizes particle
action on the epithelium, uptake by the epithelium or
depth translocation beyond the epithelial barrier [6].
Chronic obstructive pulmonary disease (COPD) is one
of the main human chronic inflammatory lung diseases
and has evolved as the fourth leading cause of death
worldwide [7]. Its pathophysiology is caused by inhaled
noxious particles and/or gases that trigger inflammatory
responses in the larger airways, i.e. chronic bronchitis, as
well as a continuous destruction of the alveolar epithe-
lium, i.e. emphysema. Symptomatically, patients suffer
from cough and dyspnea resulting from increased mucus
secretion and airflow obstruction with air trapping. It
was reported that COPD patients have a reduced NP
clearance [8] caused by decreased phagocytic activity of
alveolar macrophages [9].
Recently a murine model has been developed that re-
capitulates key features of human COPD [10-12]. The
overexpression of the β-epithelial Na+-channel (βENaC)
encoded by the Scnn1b gene causes airway surfacedehydration and impaired mucociliary clearance produ-
cing chronic mucostasis and airway inflammation. As a
result, Scnn1b-transgenic (Tg) animals develop spontan-
eous chronic bronchitis with goblet cell metaplasia and
mucus hypersecretion and emphysema with increased
lung volumes, distal airspace enlargement and increased
lung compliance [11,13].
The aim of this study was to compare the distribution
and localization of AuNP after inhalation in lung tissue,
as well as AuNP uptake by surface macrophages of
Scnn1b-Tg mice and wild-type (Wt) littermates, using
unbiased stereology. To achieve this goal, animals in-
haled an aerosol of spark generated AuNP for 2 h. At
two time points after inhalation, i.e. immediately (0 h)
and at 24 h, surface macrophages harvested by broncho-
alveolar lavage (BAL) and whole lungs were prepared for
transmission electron microscopic (TEM) analysis by
unbiased stereology.
Results
AuNP distribution and localization in lung tissue
The well-defined shape and the strong amplitude con-
trast allow unambiguous identification of AuNP in
ultrathin tissue sections by conventional TEM. As dem-
onstrated in Figure 1, AuNP were found in all constitu-
ents of the inner lung surface, i.e. in the alveolar lining
layer (surfactant), in surface macrophages, attached to
the epithelial surface, as well as within alveolar type I
and type II epithelial cells. Rarely and upon qualitative
examination of lung tissue only, AuNP were also found
beyond the epithelial barrier in endothelial cells
(Figure 1C2). AuNP were not found in the connective
tissue. Intracellular AuNP were predominantly localized
in vesicles, adjacent to the organelle’s membrane. Very
rarely and in epithelial cells only, intracellular AuNP
were found in the cytoplasm. AuNP were mainly found
as singlets or small agglomerates of ≤ 100 nm diameter.
Macrophages also contained large AuNP agglomerates
(> 100 nm).
The stereological analysis of AuNP distribution in lung
tissue is shown in Table 1 and Figure 2. The data give
evidence for changes in particle distribution between the
two time points analyzed, as well as between Scnn1b-Tg
and Wt animals: (i) at 0 h after the two-hour aerosol in-
halation, about two thirds (69.2 ± 4.9%) of AuNP were
found extracellularly on the luminal side, i.e. attached to
the epithelial surface, and one quarter (24.0 ± 5.9%) were
within macrophages in Scnn1b-Tg mice. In Wt mice,
however, one third (35.3 ± 32.2%) of AuNP were attached
to the epithelial surface and more than half (58.3 ± 41.4%)
were within macrophages. (ii) The percentage of luminal
AuNP decreased from 0 h to 24 h after aerosol inhalation,
to 15.5 ± 4.8% in Scnn1b-Tg and to 9.5 ± 5.0% in Wt mice.
This was in conjunction with an increase of the
Figure 1 Representative TEM images of AuNP in lung tissue. Singlets and small AuNP agglomerates. A) Intracellular within a vesicle of an
alveolar type I epithelial cell. B) Luminal, i.e. attached to the cell membrane of an alveolar type I epithelial cell. C1) In a vesicle of an alveolar type
II epithelial cell. C2) In a vesicle of an endothelial cell. D) In a vesicle of an alveolar macrophage. E) Attached to lining layer material, i.e. surfactant.
Arrows point to the regions shown at higher magnification in the inserts.
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18.9% AuNP were within macrophages and 19.9 ± 12.0%
within alveolar type I epithelial cells in Scnn1b-Tg mice,
while in Wt animals, 82.8 ± 0.2% AuNP were within mac-
rophages and only 2.1 ± 1.5% within alveolar type I epithe-
lial cells. (iv) Less than 5% of AuNP were attached to
surface lining layer material (surfactant) or within alveolar
type II epithelial cells in both animal groups and at both
time points studied.As shown in Table 2, there was no significant statis-
tical evidence of any mean fine pulmonary structure dif-
ference between Scnn1b-Tg and Wt mice. In addition,
we found no evidence for any significant recruitment of
macrophages to the lung surface after aerosol inhalation,
as macrophage numbers were not different in lungs
fixed at 0 h and 24 h after inhalation of the aerosol in
any experimental group. As expected, lung volumes [14]
were generally larger in Scnn1b-Tg (range: 1.41 - 1.56 mL,
Table 1 Relative distribution of AuNP (singlets, small or large agglomerates) in lung tissue compartments [%]
Animals* Lining layer Macs Epithelium
Epithelial surface Type Icells Type II cells Type I & Type II Total epithelium
Tg 0 h 1.0 ± 1.4 24.0 ± 5.9 69.2 ± 4.9 6.7 ± 1.2 0.1 ± 0.2 6.8 ± 1.0 76.0 ± 5.9
Tg 24 h 1.0 ± 1.4 63.0 ± 18.9 15.5 ± 4.8 19.9 ± 12.0 1.5 ± 2.1 21.4 ± 14.2 37.0 ± 19.0
Tg All 1.0 ± 1.2 43.5 ± 25.3 42.4 ± 31.3 13.3 ± 10.4 0.8 ± 1.5 14.1 ± 11.8 56.5 ± 25.3
Wt 0 h 3.5 ± 4.9 58.3 ± 41.4 35.3 ± 32.2 2.5 ± 3.5 0.5 ± 0.7 3.0 ± 4.2 38.3 ± 36.4
Wt 24 h 4.5 ± 6.4 82.8 ± 0.2 9.5 ± 5.0 2.1 ± 1.5 0.1 ± 0.1 2.2 ± 1.6 11.7 ± 6.6
Wt All 4.0 ± 4.7 70.5 ± 27.8 22.4 ± 24.0 2.3 ± 2.2 0.3 ± 0.5 2.6 ± 2.7 25.0 ± 26.3
Tg, Scnn1b-transgenic mice; Wt, wild-type mice. Macs, macrophages, Type I and Type II cells, alveolar epithelial cells. Total epithelium, all AuNP associated with
the alveolar epithelium, i.e. attached to and within alveolar (type I and type II) epithelial cells.
Data are presented as the mean ± SD.
*, n = 2 per genotype and time point.
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[11,13], however, without reaching statistical significance
for the number of mice included in this study.
AuNP uptake in BAL macrophages
In BAL macrophages, AuNP were found as single parti-
cles and agglomerates of variable sizes, exclusively in
vesicles. For a more detailed analysis of AuNP uptake by
macrophages, vesicles containing AuNP were subdivided
into the following size categories: (i) small primary vesi-
cles (< 150 nm in diameter), (ii) medium-sized vesicles
(150 – 1000 nm) such as endosomes or multi-vesicular
bodies and (iii) large vesicles (> 1000 nm) such as
phagosomes or lysosomes [6]. As depicted in Figure 3,Figure 2 Relative distribution of AuNP (singlets, small or large agglom
percentage of lung-retained AuNP decreased on the epithelial surface and
type I epithelial cells, an increase of AuNP was observed in Scnn1b-Tg mice
Wt mice, whereas in Scnn1b-Tg mice, the highest percentage of AuNP wer
attached to lining layer material (surfactant) and internalized by alveolar typ
remained unchanged between the two time points studied. Data are presesingle AuNP or small agglomerates were found in small
vesicles, whereby vesicle size still largely exceeded
particle size. AuNP agglomerates of > 100 nm in diam-
eter were predominantly localized in the medium-sized
and large vesicles, which usually contained no other
electron-dense material. Association of AuNP with the
vesicular membrane was observed for particles in vesi-
cles of all size categories.
The data of AuNP uptake in BAL macrophages,
assessed by the relative deposition index (RDI) [15,16],
are shown in Table 3. The results demonstrate that the
number of observed particles in macrophages (NO) is
significantly higher (RDI > 1) than the expected number
of particles (NE) in Wt animals at 0 h (RDI = 1.3) and inerates) in lung tissue. From 0 h to 24 h after aerosol inhalation, the
increased in macrophages in both animal groups, while in alveolar
only. At 0 h, the percentage of AuNP was highest in macrophages of
e registered on the epithelial surface. The percentage of AuNP
e II epithelial cells was low (less than 5%) in both animal groups and
nted as mean values of n = 2 animals per genotype and time point.
Table 2 Lung volume and fine pulmonary structure
Animals V(lung) [ml] Air/tissue [%] Tissue distribution [%]
Connective tissue Capillaries Macs 0 h/24 h Type I cells Type II cells
Tg (n = 4) 1.48 ± 0.06 86.0 ± 0.8/14.0 ± 0.8 36.8 ± 14.2 38.2 ± 19.6 2.9 ± 2.6/2.0 ± 2.2 19.1 ± 6.9 3.5 ± 0.4
Wt (n = 4) 1.27 ± 0.21 86.0±0.6/13.5±1.4 32.4 ± 11.0 36.3 ± 24.4 3.1 ± 3.0/3.9 ± 4.7 23.3 ± 11.0 4.9 ± 3.3
V (lung), lung volume [14]; Tg, Scnn1b-transgenic mice; Wt, wild-type mice; Macs, macrophages. Type I and Type II cells, alveolar epithelial cells. Data are
presented as the mean ± SD.
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ation. For the remaining two animal groups, the number
of observed particles in macrophages was lower than
expected (RDI < 1), i.e. not significantly different from
what could be expected.
Discussion
Unbiased stereology combined with TEM allows quanti-
tative assessment of the ultrastructural localization and
distribution of inhaled NP in lungs at the individual par-
ticle level. In the present study, we investigated the
distribution of inhaled 21-nm AuNP in whole lungs and
in BAL macrophages in a transgenic mouse model of
COPD in comparison to wild-type mice, at 0 h and 24 h
after the inhalation of the aerosol by negative-pressure
ventilation for 2 h.
Stereological analysis of particle distribution in lungs
demonstrated a rapid association of AuNP with the epi-
thelial surface, i.e. alveolar type I epithelial cells, which
cover 95% or more of the alveolar surface area [17].
These data are in agreement with results of a recent
study about the influence of surfactant protein D on theFigure 3 Representative TEM images of AuNP in BAL macrophages. A
(> 100 nm in diameter) were predominantly localized in medium-sized (15
AuNP agglomerates (< 100 nm) were localized in small vesicles (< 150 nm
Note the close localization of the AuNP to the organell’s membrane.biodistribution of inhaled 22-nm AuNP in mice, where a
high fraction of AuNP retained in lungs were shown to
be associated with the lung tissue [18]. Ultrastructural
TEM analysis allowed in addition distinguishing AuNP
attached to the cell membrane from those internalized.
The results revealed similarities but also differences be-
tween the two animal groups, as well as between the
two time points studied: Overall, the percentage of
AuNP associated with the alveolar epithelium, i.e. those
attached to and within alveolar type I or type II epithelial
cells (Table 1) was substantially higher in Scnn1b-Tg
(56.5 ± 25.3%, mean over all animals and time points)
than in Wt lungs (25.0 ± 26.3%). Conversely, the per-
centage of AuNP was substantially higher in macro-
phages of Wt (70.5 ± 27.8%, mean values over all
animals and time points) than of Scnn1b-Tg animals
(43.5 ± 25.3%). In both animal groups, the percentage of
AuNP attached to the epithelium was lower at 24 h than
at 0 h and concomitantly, the percentage of AuNP in
macrophages was higher at 24 h than at 0 h after aerosol
inhalation. In Wt animals, AuNP appeared to be rapidly
removed from the alveolar surface by macrophages. In, B) Scnn1b-Tg mice. C, D) Wt mice. A, C) Large AuNP agglomerates
0 – 1000 nm) and large vesicles (> 1000 nm). B, D) Single or small
), whereby the vesicle diameters still largely exceeded particle size.
Table 3 Uptake of AuNP in BAL macrophages at 0 h and
24 h after aerosol inhalation
Animals NO NP NE RDI Partial χ
2 Partial χ2as%
Wt 0 h 95 35392 75.7 1.3* 4.9 37.6
Wt 24 h 52 33328 71.3 0.7 5.2 62.4
Total 147 68720 10.1
Tg 0 h 29 18688 42.2 0.7 4.1 48.5
Tg 24 h 83 30944 69.8 1.2* 2.5 51.7
Total 112 49632 6.6
NO, number of observed particles; NP, number of observed points (hitting a
macrophage) per animal; NE, number of expected particles; RDI, relative
deposition index. *RDI > 1 and partial χ2 > 30% indicate a preferentially
populated compartment, i.e. more AuNP were found than expected for
random AuNP distribution. Tg, Scnn1b-transgenic mice; Wt, wild-type mice.
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macrophages appeared to be less efficient. In addition, a
substantial part of AuNP was found internalized by the
primary surface-covering alveolar epithelial type I cells in
Scnn1b-Tg mice; 6.7 ± 1.2% at 0 h and 19.9 ± 12.0% at
24 h after the inhalation of the aerosol. Less efficient
uptake of AuNP by surface macrophages in lungs of
Scnn1b-Tg mice was confirmed by the results of AuNP in-
ternalization in BAL macrophages, which is further de-
scribed below. Hence, the results from lung tissue analysis
provide evidence for a prolonged residence time of AuNP
on the lung surface in chronic obstructive lung disease in
Scnn1b-Tg mice resulting in increased NP uptake by epi-
thelial cells. These findings are of interest for therapeutic
targeting of epithelial cells in COPD/emphysema. A
prolonged residence time of AuNP on the alveolar surface
and augmented AuNP uptake by the primary surface-
covering alveolar type I epithelial cells in addition enhance
the probability of AuNP translocation into the adjacent
endothelial cells and into the blood capillaries and, hence,
further systemic distribution of AuNP [19]. In case of
inhaled harmful NP, this may be an important factor in
disease initiation or for alterations in the course of disease,
i.e. exacerbation.
Because stereological analysis did not result in any
AuNP in the connective tissue, we consider particle ac-
cumulation in this lung compartment to be negligible.
However, we have evidence for AuNP translocation be-
yond the epithelium from qualitative TEM analysis, as
we found AuNP –though a few only– in endothelial cells
of capillaries (Figure 1C2). Thus, these results are also in
agreement with the findings in the AuNP-biodistribution
study in mice, where rapid systemic translocation of a
small fraction of AuNP was reported [18]. Similarly, in
rat lungs, only a small fraction of inhaled AuNP was
reported to translocate to the systemic circulation by
crossing the air-blood barrier [20,21].
Particle uptake by resident surface macrophages and
their further migration to airways and mucociliarytransport to the larynx is the main mechanism for par-
ticle clearance from the peripheral lungs [19]. In the
present study, there is consistent evidence for less effi-
cient AuNP uptake by macrophages in Scnn1b-Tg com-
pared to Wt animals and, hence, for limited macrophage
clearance of NP in diseased lungs: (i) data of AuNP dis-
tribution in whole lungs (Table 1, Figure 2) revealed
considerably lower percentages of AuNP internalized by
macrophages in Scnn1b-Tg than in Wt mice at both
time points studied (0 h and 24 h); (ii) analysis of AuNP
uptake in BAL macrophages (Table 3) revealed a RDI =
1.3 in Wt animals at 0 h, indicating that deposited AuNP
were rapidly and more eagerly internalized than at 24 h
by the same condition group (RDI = 0.7). In contrast, in
Scnn1b-Tg animals, the RDI was 1.2 at 24 h and higher
than at 0 h (RDI = 0.7), indicating delayed AuNP clear-
ance from the epithelial surface by macrophages in this
animal group.
AuNP in macrophages and in alveolar type I epithelial
cells were mainly found in vesicles (Figure 1 and Figure 3).
This is in agreement with studies in rats, where AuNP
were also observed in vesicles of the same cell types
[20,21]. Likewise, in an in vitro study with BAL macro-
phages, AuNP were found in pinocytic vesicles and
lysosomes [22]. This is in line with other reports on intra-
vesicular particle localization, suggesting NP uptake by
cells to mainly occur by endocytic processes [16]. The var-
iety of vesicular structures in which we observed AuNP
indicate different endocytosis mechanisms [23]. AuNP
found as singlets or small agglomerates (< 100 nm in
diameter) in vesicles of all cell types reflect pinocytic up-
take. Vesicles containing large AuNP agglomerates of
500 nm diameters or more, found in macrophages only,
demonstrate phagocytosis that allows uptake of microm-
eter sized objects.
We very rarely found AuNP in the cytoplasm of alveo-
lar type I epithelial cells, suggesting that passive uptake
of NP, i.e. not triggered by receptor-ligand interactions,
is not a major pathway for AuNP uptake by alveolar epi-
thelial cells. Cytoplasmic localization of inhaled NP has
been reported for inhaled 20-nm TiO2NP in rat lungs
[24]. The difference between TiO2 and AuNP in regard
to cytoplasmic localization might be explained by the
finding that in contrast to AuNP, we did not observe
TiO2NP bound to the apical surface of epithelial cells in
rat lungs. So, it might be that AuNP bind to surface re-
ceptors that are constitutively or abundantly expressed
on alveolar epithelial cells, while TiO2NP do not bind to
such receptors but are more likely to enter the cell by
non-adhesive forces as we have previously suggested [24].
AuNP attached to the epithelial surface were exclu-
sively found as singlets or small agglomerates. Since we
registered macrophages containing large particle ag-
glomerates at the same time points, this may indicate
Table 5 Calculated AuNP deposition density on the
alveolar epithelium
Parameter Value
CMD of Au NP (nm) 21
Volume of AuNP (cm3), calculated median volume of
spherical AuNP with density given below
4.9 × 10-18
Nominal density of Au (g/cm3) 19.3
Mass of AuNP (g), calculated from data above 9.4 × 10-17
AuNP aerosol mass concentration (mg/m3), calculated
from data in Table 4 and Table 5
1.20
Number of AuNP deposited in lungs, 120 min,
calculated from data in Table 4 and Table 5
1.3 × 1010
AuNP deposited mass, 120 min (g) calculated from data
in Table 4 and Table 5
1.24 × 10-6
Total projected area of all AuNP deposited (cm2)
calculated from data above
2.2 × 10-10
Lung surface area (cm2), [25] 400
Fraction of NP coverage of lung surface (cm2)
calculated from data above
5.5 × 10-13
Mean linear distance between 2 NP (nm), [25] 7.4
CMD, count median diameter.
Geiser et al. Particle and Fibre Toxicology 2013, 10:19 Page 7 of 10
http://www.particleandfibretoxicology.com/content/10/1/19efficient macrophage clearance of agglomerated but not
of single AuNP from the lung surface. This is in line
with the results of all analyses in this study.
The concomitant finding of single or small agglomer-
ates of AuNP (on the alveolar surface and within any cell
types) and of large agglomerates (in macrophages only)
is not easily explained. Under the laminar flow condi-
tions in the alveolar region, the deposition mechanism
of the 21-nm AuNP is maintained by diffusion leading
to a rather homogeneous deposition density throughout
the entire alveolar epithelium. Estimating the cross sec-
tional surface of all deposited AuNP in relation to the al-
veolar surface area of 400 cm2 in mice (see Table 4 and
Table 5), the statistical mean distance between two de-
posited AuNP is about half of the mean AuNP diameter
of 21 nm. Hence, coagulation of neighboring AuNP can
only occur to a limited extent leading to AuNP singlets
and small agglomerates. This is in agreement with our
findings of AuNP singlets and small agglomerates on
and within alveolar epithelial cells, within endothelial
cells and within some macrophages. Following our esti-
mate on the AuNP density on the epithelial surface, the
large agglomerates, which were exclusively observed in
macrophages, may be indicative for intracellular fusion
of vesicles and, hence, a “retrograde” formation of larger
agglomerates inside macrophages. Such large AuNP ag-
glomerates were also found in a previous inhalation
study in rats using similar AuNP types, however, prefer-
entially at later time points [20,21].
Conclusions
This, to our knowledge, first study on the ultrastructural
distribution of inhaled AuNP by unbiased stereology inTable 4 Characteristics of the inhaled AuNP aerosol
Parameter Value
Aerosol concentration (p/cm3), continuously measured
and averaged over the entire study time; subsequent
averaging of data over all inhalation periods
1.28 ± 0.08
× 107
Inhalation period (min), experimentally set 120
Tidal volume (cm3), estimated from pneumotachograph
signals
0.18
Breathing frequency (1/min), experimentally set 120
Minute volume (cm3/min), calculated from data above 21.6
Inhaled volume (L/120 min), calculated from data above 2.6
Deposition fraction, based on MPPD model 0.4
CMD of AuNP (nm)/GSD, measured continuously as
described in text and averaged over all inhalation periods
21/1.6
Number of AuNP inhaled, calculated from data above 3.3 × 1010
Number of AuNP deposited in lungs, calculated from
data above
1.3 × 1010
MPPD, multiple-path particle dosimetry (computational model to estimate
human and rodent particle dosimetry). CMD, count median diameter; GSD,
geometric standard deviation.Scnn1b-Tg mice with COPD and healthy Wt littermates
gives further insight into the interaction of deposited NP
with fine pulmonary structures. We observed rapid
binding of AuNP to the alveolar epithelium, i.e. to the
primary surface-covering alveolar type I epithelial cells
in both animal groups. In Scnn1b-Tg mice, we found de-
layed and less uptake of AuNP by surface macrophages
and concomitant higher AuNP uptake by alveolar type I
epithelial cells compared to Wt mice. In case of inhaled
harmful NP, this may be an important factor in disease
initiation or for alterations in the course of disease, i.e.
exacerbation. Conversely, a prolonged residence time of
deposited AuNP on the epithelial surface and increased
NP uptake by the alveolar epithelium may be favorable
for therapeutic targeting of the lung parenchyma by
inhaled aerosols in COPD/emphysema. To unravel NP-
lung interaction, more studies with diseased lungs are
required.
Materials and methods
Experimental design
To resolve the interaction of AuNP with the inner lung
surface, we studied (i) AuNP distribution in lung tissue
and (ii) AuNP uptake by surface macrophages, at the in-
dividual particle level, immediately (0 h) and 24 h after a
2-hour aerosol inhalation, in Scnn1b-Tg mice and Wt
littermates.
Animals
Scnn1b-Tg mice (congenic line generated in a mixed
C3H/HeN:C57BL/6 N background [11]) and Wt litter-
mates were bred and reared at the University of
Figure 4 Representative TEM image of AuNP aerosol.
Morphology of freshly generated AuNP aerosol for inhalation
collected on formvar-coated copper grids using a TEM particle
sampler (University of Applied Sciences). The spherical shape was
obtained after melting of AuNP in the airborne state by heat
treatment at 600°C [28].
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genotyped by tail biopsy polymerase chain reaction (PCR)
as previously described [26]. Specified pathogen-free
status was approved by a health certificate according to
Federation of European Laboratory Animals Science As-
sociation (FELASA) guidelines. For the experiments, mice
were transferred to the animal facility of the Institute of
Lung Biology and Disease at the Helmholtz-Center
Munich, Neuherberg/Munich, Germany. They were
housed in individually ventilated cages (IVC; BioZone,
Ramsgate, UK) supplied with filtered air and access to
food and water ad libitum. Mice were kept on a 12 h day/
night cycle, humidity was maintained at 55% and the
temperature was 22°C.
All experiments were conducted under federal guide-
lines for the use and care of laboratory animals and were
approved by the Bavarian Animal Research Authority
and by the Helmholtz Center’s Institutional Animal Care
and Use Committee, the Animal Care and Use Commit-
tee of the Regierungspräsidium Karlsruhe, Germany, as
well as in accordance with the Swiss Federal Act on
Animal Protection and the Swiss Animals Protection
Ordinance.
Six Scnn1b-Tg and six Wt mice (females, age: 10 –
18 weeks, body weights: 22 - 33 g) were used. There were
no significant differences in age or body weight between
mutant and Wt mice. For particle inhalation and for lung
fixation prior to euthanasia by exsanguination via the ab-
dominal aorta, animals were anesthetized by intraperitoneal
(i.p.) injection of a mixture of medetomidine (Domitor®,
Pfizer GmbH, Karlsruhe, Germany; 0.5 mg/kg body
weight), midazolam (Dormicum®, Hoffmann-La Roche AG,
Grenzach-Wyhlen, Germany; 5 mg/kg) and fentanyl
(Fentanyl®, Janssen-Cilag GmbH, Neuss, Germany;
0.05 mg/kg). For examinations at 24 h, anesthesia was
antagonized by subcutaneous injection of atipamezole
(Antisedan®, Pfizer GmbH Karlsruhe, Germany; 2.5 mg/
kg), flumazenil (Anexate®, Hoffmann-La Roche AG,
Grenzach-Wyhlen, Germany; 0.5 mg/kg), and naloxone
(Narcanti®, Janssen Animal Health, Neuss, Germany;
1.2 mg/kg).
Aerosol generation and inhalation
AuNP aerosol generation and inhalation were performed
as previously described for titanium dioxide NP [27] and
gold NP [28]; relevant data are shown in Table 4 and
Table 5. Briefly, AuNP aerosols were generated with a
spark generator (GFG100, Palas, Karlsruhe, Germany),
quasi-neutralized with a radioactive 85Kr source, heat-
treated at 600°C in a tube furnace for melting the
AuNP agglomerates to spherical AuNP, diluted and con-
ditioned for inhalation in terms of gas composition, hu-
midity and temperature. Particle number concentration
and size distribution were continuously monitored by acondensation particle counter (CPC 3022A, TSI,
Aachen, Germany) and a scanning differential electrical
mobility particle sizer (SMPS, Classifier 3071 and CPC
3010, TSI), respectively. The aerosol produced for inhal-
ation had a count median diameter (CMD) of about
21 nm (geometric standard deviation, GSD = 1.6) and a
mean number concentration of 1.28 ± 0.08 × 107
nanoparticles/cm3 throughout the exposures; due to the
high gold density of 19.3 g/cm3 the estimated mass con-
centration was 1.2 mg/m3. In addition, AuNP were
sampled for morphologic analysis on filters and on
formvar-coated copper grids after aerosol generation
using a TEM particle sampler (University of Applied Sci-
ences, Windisch, Switzerland). A representative image of
the inhaled aerosol is shown in Figure 4. Anesthetized
mice were placed in airtight plethysmograph boxes for
2 h and inhaled the aerosol via an endotracheal tube by
negative-pressure ventilation (−1.5 kPa) with 0.25 sec of
inspiration followed by 0.25 sec of expiration at ambient
air pressure, resulting in a breathing frequency of 120
breaths/min. The deposited amount of AuNP was calcu-
lated to be 1.24 μg or 1.3 × 1010 NP in each mouse lung
assuming a 40% deposition probability. We used the
CMD to estimate the deposition fraction, since under
the given thermodynamic conditions during breathing a
mass median aerosol diameter (MMAD) is not defined
due to negligible sedimentation and deposition is only
determined by diffusion, which is independent of the
density of AuNP of 21 nm diameter. During the second
hour of ventilation, 1.5% isoflurane gas was added to the
aerosol in order to maintain the mice under anesthesia.
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Lung tissue
Lungs (n = 8, two per genotype and time point) were
fixed in situ by airway instillation of phosphate-buffered
2.5% glutaraldehyde (Agar Scientific Ltd., Stansted, Essex,
England; 350 mOsm, pH 7.4) at a pressure of 25 cm H2O,
as previously described [29]. Thereafter, lungs were re-
moved in toto from the thorax and stored for at least 24 h
in fixative solution at 4°C. Lungs were then subjected to
systematic tissue sampling, post-fixed with buffered 1.0%
osmium tetroxide (Simec, Zofingen, Switzerland) and
0.5% uranyl acetate (Fluka Chemie GmbH, Sigma-Aldrich,
Buchs, Switzerland), dehydrated in a graded series of etha-
nol and acetone, and finally embedded in epon (Fluka), as
previously described [19,30]. Ultrathin sections (≤ 50 nm)
were cut from 6 - 8 tissue blocks per animal, mounted
onto formvar-coated 200-mesh copper grids and post-
stained with uranyl acetate and lead citrate (Ultrastain;
Leica, Glattbrugg, Switzerland). Ultrathin lung sections, i.
e. twelve systematic fields (every second field with random
start) per section, were analyzed for (i) lung tissue com-
position at 400 × magnification and (ii) AuNP morph-
ology and localization at 7100 × magnification, using a FEI
Morgagni 268D TEM operated at 80 kV. AuNP were ana-
lyzed according to their shape and size (single or agglom-
erated) as well as in regard to their anatomical-histological
and sub-cellular localization. The following associations
with the lung tissue were discerned: surface macrophage,
alveolar type I and type II epithelial cells, alveolar lining
layer, luminal, i.e. attached to the epithelial surface, and
connective tissue.
BAL macrophages
To recover surface macrophages, lungs (n = 4, one ani-
mal per genotype and time point) were lavaged in situ
with 5 × 1 ml divalent cation free phosphate buffered
saline (PBS) (Sigma-Aldrich, Taufkirchen, Germany)
under gentle massage of the thorax [31]. To prevent fur-
ther particle uptake by cells, recovered BAL fluid was
immediately mixed with equal amounts of phosphate-
buffered 2.5% glutaraldehyde. Thereafter, BAL fluid was
centrifuged, cells were resuspended in fresh glutaralde-
hyde and then further prepared for TEM analysis as de-
scribed above. Ultrathin sections of the cell pellets were
stereologically analyzed for AuNP uptake by surface
macrophages with a CM12 TEM operated at 80 kV
(Philips, Eindhoven, The Netherlands).
Stereology and statistics
Stereological analysis of TEM images from the systematic
fields sampled on ultrathin tissue sections was performed
with the STEPanizer software version 1 [15,32]. The fine
pulmonary structure and AuNP uptake in BAL macro-
phages were evaluated using point counting test systems.Data of Scnn1b-Tg and Wt animals were compared using
the nonparametric Mann–Whitney Rank Sum Test. The
level of significance was set at p < 0.05.
AuNP distribution within BAL macrophages was
assessed by the relative deposition index (RDI), which
indicates whether the number of observed particles in a
defined compartment (NO) is higher (RDI > 1), equal
(RDI = 1) or lower (RDI < 1) than the expected number
of particles (NE) that could be predicted considering the
compartment volume [15,16]. If the observed number of
particles, NO, equalizes or is below the expected number
of particles, NE, the distribution of NP follows a random
distribution among the compartment studied. Here the
compartment of interest was the BAL macrophage, in
which AuNP distribution was compared between Scnn1b-
Tg and Wt animals. The expected number of particles for
each animal, NE, was calculated from the total number of
observed AuNP, NO(total), the number of points observed
within the compartment of interest at one time point (0 h
or 24 h), NP and the total number of observed points
within the compartment of interest (NP(total)) using the
following equation:
NE ¼ NO totalð Þ  NP=NP totalð Þð Þ
With NO and NE, the relative deposition index (RDI)
was calculated for each animal:
RDI ¼ NO=NE
NO and NE of Scnn1b-Tg and Wt mice at 0 h and 24 h
were then statistically compared using the chi squared
(χ2) test [15,33]. RDI > 1 and partial χ2 > 30% (Partial χ2 =
(NO −NE)
2/NE) indicate a preferentially particle loaded
compartment, meaning here that a higher number of
AuNP were found within BAL macrophages than expected
for random AuNP distribution.
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